Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow-to-Debt Ratio
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow-to-Debt Ratio of 0.61x as of December 2025, meaning its operating cash flow of AU$12.52 Million could theoretically repay 1% of its total liabilities (AU$20.68 Million) in one year. See Clinuvel Pharmaceuticals Ltd (CUV) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clinuvel Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Clinuvel Pharmaceuticals Ltd across 24 annual periods. Also explore Clinuvel Pharmaceuticals Ltd (CUV) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Clinuvel Pharmaceuticals Ltd (2001–2025)
Year-by-year debt coverage analysis for Clinuvel Pharmaceuticals Ltd. For market capitalisation and broader financial context, see Clinuvel Pharmaceuticals Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.33x | AU$41.10 Million | AU$30.94 Million | ▲ +0.8% |
| 2024 | 1.32x | AU$37.05 Million | AU$28.11 Million | ▲ +6.7% |
| 2023 | 1.23x | AU$36.91 Million | AU$29.89 Million | ▼ -40.4% |
| 2022 | 2.07x | AU$39.87 Million | AU$19.25 Million | ▲ +5.7% |
| 2021 | 1.96x | AU$19.26 Million | AU$9.83 Million | ▲ +30.9% |
| 2020 | 1.50x | AU$14.19 Million | AU$9.48 Million | ▼ -58.1% |
| 2019 | 3.57x | AU$18.46 Million | AU$5.17 Million | ▲ +6.6% |
| 2018 | 3.35x | AU$11.69 Million | AU$3.49 Million | ▲ +6.9% |
| 2017 | 3.14x | AU$9.92 Million | AU$3.16 Million | ▲ +243.4% |
| 2016 | -2.19x | AU$-5.04 Million | AU$2.30 Million | ▼ -17.7% |
| 2015 | -1.86x | AU$-4.53 Million | AU$2.44 Million | ▲ +33.3% |
| 2014 | -2.79x | AU$-4.81 Million | AU$1.73 Million | ▲ +20.1% |
| 2013 | -3.49x | AU$-6.89 Million | AU$1.98 Million | ▲ +17.9% |
| 2012 | -4.25x | AU$-10.02 Million | AU$2.36 Million | ▼ -68.3% |
| 2011 | -2.52x | AU$-9.49 Million | AU$3.76 Million | ▲ +34.0% |
| 2010 | -3.82x | AU$-11.78 Million | AU$3.08 Million | ▼ -58.9% |
| 2009 | -2.41x | AU$-10.99 Million | AU$4.56 Million | ▼ -5.8% |
| 2008 | -2.28x | AU$-7.18 Million | AU$3.16 Million | ▲ +32.3% |
| 2007 | -3.36x | AU$-8.18 Million | AU$2.43 Million | ▲ +9.1% |
| 2006 | -3.70x | AU$-11.40 Million | AU$3.08 Million | ▼ -4.1% |
| 2005 | -3.55x | AU$-9.25 Million | AU$2.60 Million | ▲ +17.5% |
| 2004 | -4.31x | AU$-6.00 Million | AU$1.39 Million | ▲ +63.5% |
| 2002 | -11.81x | AU$-2.49 Million | AU$210.83K | ▼ -630.6% |
| 2001 | -1.62x | AU$-514.54K | AU$318.26K | — |